p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab

Mounting evidence supports the role of p53 in metabolic processes involved in breast carcinogenesis. We investigated whether p53 status affects the association of pre-treatment fasting glucose with treatment outcomes in 106 non diabetic, HER2 positive breast cancer patients treated with trastuzumab....

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Vici, Patrizia, Sperati, Francesca, Maugeri-Saccà, Marcello, Melucci, Elisa, Benedetto, Anna Di, Lauro, Luigi Di, Pizzuti, Laura, Sergi, Domenico, Terrenato, Irene, Esposito, Luca, Iannuzzi, Carmelina Antonella, Pasquale, Raffaella, Botti, Claudio, Fuhrman, Barbara, Giordano, Antonio, Mottolese, Marcella, Barba, Maddalena
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2014
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279380/
https://ncbi.nlm.nih.gov/pubmed/25071015
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items